The use of AChE inhibitors in order to enhance cholinergic function in the brain is the main strategy in treatment of Alzheimer’s disease (AD) which is characterized by loss or decline in memory and cognitive impairment (2, 3). This evidence concerns the gene ACHE and Alzheimer disease.